Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Aug;42(1):32-8.
doi: 10.1007/s12035-010-8129-1. Epub 2010 Apr 30.

Role of platelet-activating factor in cell death signaling in the cornea: A review

Affiliations
Review

Role of platelet-activating factor in cell death signaling in the cornea: A review

Salomon Esquenazi et al. Mol Neurobiol. 2010 Aug.

Abstract

Platelet-activating factor (PAF) is a potent bioactive lipid generated in the cornea after injury whose actions are mediated through specific receptors. Studies from our laboratory have shown that PAF interactions with its receptors activate several transmembrane signals involved in apoptosis. Continuous exposure to PAF during prolonged inflammation increases keratocyte apoptosis and inhibition of epithelial adhesion to the basement membrane. As a consequence, there is a marked delay in wound healing, which is not countered by the action of growth factors. While apoptosis of stroma cells is rapid and potent, epithelial cells as well as myofibroblasts, which appear in the stroma during the repair phase, are resistant to apoptosis. However, PAF accelerates apoptosis of corneal epithelial cells exposed to oxidative stress by stimulating phospholipase A2, producing an early release of cytochrome C from mitochondria and activating caspase-3. In myofibroblasts, PAF has a synergistic action with tumor necrosis factor-alpha (TNF-alpha), increasing apoptosis of the cells to 85%. PAF antagonists block the effects of PAF and could have a therapeutic role in maintaining a healthy and transparent cornea.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Diagram of the structural organization of the cornea
Fig. 2
Fig. 2
Transformation of stromal keratocytes after injury in fibroblasts and myofibroblasts and expression of PAF-R in the cells. α-SMA α-smooth muscle actin
Fig. 3
Fig. 3
Synthesis of PAF by the remodeling pathway. Corneal injury activates PLA2, which releases AA to form lyso-PAF, a biologically inactive intermediate that, by the action of an acetyltransferase, synthesizes PAF. During corneal injury, the rate of PAF synthesis is higher than the degradation and, as a consequence, PAF accumulates [7]
Fig. 4
Fig. 4
Signaling pathway of apoptosis stimulated by PAF in corneal epithelial cells. Apoptosis can be induced by UV irradiation. PAF accelerates the process of releasing cytochrome c and activating the caspase cascade that results in early DNA fragmentation and apoptosis. cPLA2 activation is involved in the process. Although the mechanism is not known, one possibility is that AA can regulate mitochondrial permeability and stimulate the release of cytochrome c. The cPLA2 inhibitor MAFP blocks the effect of PAF on the release of cytochrome c and, as a consequence, increases the time of DNA fragmentation after UV exposure [36]. Apaf-1 apoptotic protease-activating factor-1
Fig. 5
Fig. 5
Scheme on the action of PAF in corneal cells. While stromal keratocytes enter into apoptosis in the presence of PAF, there is a synergistic effect in apoptosis of myofibroblasts when TNF-α is combined with PAF. Epithelial cells are resistant to PAF apoptosis, but the lipid mediator accelerates the process after UV irradiation

Similar articles

Cited by

References

    1. Birk DE, Fitch JM, Linsenmayer TF. Organization of collagen type I and V in the embryonic chicken cornea. Invest Ophthalmol Vis Sci. 1986;27:1470–1477. - PubMed
    1. Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE. Stromal haze, myofibroblasts and surface irregularity after PRK. Exp Eye Res. 2006;82:788–797. - PMC - PubMed
    1. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from physician’s health studies. Arch Ophthalmol. 2009;127:763–768. - PMC - PubMed
    1. Green M, Apel A, Stepleton F. A longitudinal study of trends in keratitis in Australia. Cornea. 2008;27:33–39. - PubMed
    1. Pfister RR, Burnstein N. The alkali burned cornea: I: epithelial and stromal repair. Exp Eye Res. 1976;23:519–535. - PubMed

Publication types

Substances